Old Saybrook, CT, United States of America

David Andrew Griffith

This inventor holds 65 USPTO granted patents and 18 published patent applications, plus 7 CIPO patents and 13 EPO patents, primarily in GLP-1 Receptor Agonists (CPC class C07D). Top assignees: Pfizer Corporation, Apple Inc., F-Origin, Inc. Active years: 2001-2026.

USPTO Granted Patents = 65 (Patent Applications = 18)

% Patents Active = 67.7

CIPO Patents = 7 (Patent Applications = 6)

EPO Patents = 13 (Patent Applications = 20)

Average Co-Inventor Count = 3.2

ph-index = 11

Forward Citations = 566(Granted Patents)

Forward Citations (Not Self Cited) = 460(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Old Saybrook, CT (US) (2001 - 2014)
Cambridge, MA (US) (2014)
Apex, NC (US) (2012 - 2018)
Rocky View County, CA (2019)
Sudbury, MA (US) (2013 - 2024)

Company Filing History:

Pfizer, Inc. Patent Department

patent

6. 6 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

GLP-1 Receptor Agonists

BCKDK Inhibitors

Cannabinoid Receptor Ligands

N1-Pyrazolospiroketone

Acetyl-CoA Carboxylase Inhibitors

Hybrid Force Sensitive Devices

Metabolites

Touch Screen Technology

Automatic Downhole Jetting

Friction-Less Movement

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12611401 - Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases (2026-04-28),

2. 12466803 - BCKDK inhibitors and/or degraders (2025-11-11),

3. 12378230 - GLP-1 receptor agonists and uses thereof (2025-08-05),

4. 12331041 - GLP-1 receptor agonists and uses thereof (2025-06-17),

5. 12319669 - GLP-1 receptor agonists and uses thereof (2025-06-03),

6. 12065434 - Metabolites of GLP1R agonists (2024-08-20),

7. 11858916 - GLP-1 receptor agonists and uses thereof (2024-01-02),

8. 11802121 - GLP-1 receptor agonists and uses thereof (2023-10-31),

9. 11673890 - N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors (2023-06-13),

10. 11542270 - BCKDK inhibitors (2023-01-03),

11. 11512070 - GLP-1 receptor agonists and uses thereof (2022-11-29),

12. 11059833 - BCKDK inhibitors (2021-07-13),

13. 10934279 - GLP-1 receptor agonists and uses thereof (2021-03-02),

14. 10851081 - GLP-1 receptor agonists and uses thereof (2020-12-01),

15. 10822335 - N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors (2020-11-03),

Title: The Innovative Mind of David Andrew Griffith

Introduction: David Andrew Griffith, a talented inventor hailing from Old Saybrook, CT, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: David Andrew Griffith's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a sustainable energy solution for rural communities, and a smart home automation system for enhanced convenience and security.

Career Highlights: With a career spanning over two decades, David Andrew Griffith has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with numerous awards and accolades in the tech industry.

Collaborations: Throughout his career, David Andrew Griffith has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful commercialization of several groundbreaking technologies.

Conclusion: In conclusion, David Andrew Griffith's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor in the field of technology. His contributions continue to shape the future of various industries, leaving a lasting impact on society as a whole.